Cardiovascular-Kidney-Metabolic (CKM) Syndrome in the Asia-Pacific: Tackling this highly prevalent condition with an equity focus

Big Issues

PROUDLY HOSTED BY

SESSION RECORDING

This session explored the pressing challenges and potential opportunities in tackling Cardio-vascular kidney metabolic (CKM) Syndrome in the Asia-Pacific region with an equity-focused approach. Speakers highlighted the rising prevalence of cardiovascular, kidney, and metabolic diseases, particularly in Fiji and Malaysia, stemming from lifestyle choices, limited healthcare access, and disparities in healthcare delivery.

Key themes included the importance of equity in healthcare, innovative solutions leveraging technology, access to affordable medications, and the need for collaboration and capacity building. While addressing these challenges presents significant hurdles, there are opportunities for improving health outcomes through comprehensive public policies, community empowerment, and leveraging advancements in technology and research.

SESSION SUMMARY

Clare Arnott
Global Director of Cardiovascular Program, The George Institute for Global Health, Australia

Sophia Zoungas
Head, School of Public Health and Preventive Medicine, Monash University, Australia

SESSION MODERATORS

Atonio Rabici Lalabalavu
Minister of Health and Medical Services, Fiji Government

Lee-Ling Lim
Deputy Head, Visibility, Information & Communication Unit, Faculty of Medicine (VICFOM), University of Malaya; Head of Diabetes Care Unit & Senior Consultant Endocrinologist, University of Malaya Medical Centre

Stephen Nicholls
Director, Victorian Heart Hospital, Australia

Alta Schutte
Principal Theme Lead, Cardiac, Vascular and Metabolic Medicine, University of New South Wales, Australia

INVITED SPEAKERS